CA1184495A - Process of producing pharmaceutical composition of famotidine for injection - Google Patents

Process of producing pharmaceutical composition of famotidine for injection

Info

Publication number
CA1184495A
CA1184495A CA000417637A CA417637A CA1184495A CA 1184495 A CA1184495 A CA 1184495A CA 000417637 A CA000417637 A CA 000417637A CA 417637 A CA417637 A CA 417637A CA 1184495 A CA1184495 A CA 1184495A
Authority
CA
Canada
Prior art keywords
famotidine
acid
injection
aspartic acid
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000417637A
Other languages
English (en)
French (fr)
Inventor
Masayoshi Aruga
Norio Nakajima
Norishige Saisho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA1184495A publication Critical patent/CA1184495A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000417637A 1981-12-15 1982-12-14 Process of producing pharmaceutical composition of famotidine for injection Expired CA1184495A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56201934A JPS58103312A (ja) 1981-12-15 1981-12-15 難溶性医薬品の注射剤用水溶液
JP201934/1981 1981-12-15

Publications (1)

Publication Number Publication Date
CA1184495A true CA1184495A (en) 1985-03-26

Family

ID=16449204

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000417637A Expired CA1184495A (en) 1981-12-15 1982-12-14 Process of producing pharmaceutical composition of famotidine for injection

Country Status (7)

Country Link
JP (1) JPS58103312A (ko)
KR (1) KR880001632B1 (ko)
CA (1) CA1184495A (ko)
ES (1) ES8405613A1 (ko)
GR (1) GR77823B (ko)
MX (1) MX7581E (ko)
PT (1) PT75985B (ko)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051411A1 (fr) * 2000-12-22 2002-07-04 Yamanouchi Pharmaceutical Co., Ltd. Injections de famotidine
CN111904936A (zh) * 2020-08-28 2020-11-10 开封康诺药业有限公司 一种法莫替丁冻干粉针剂
CN114028342A (zh) * 2021-12-08 2022-02-11 广东彼迪药业有限公司 一种法莫替丁速崩颗粒、法莫替丁片及制备方法
CN114681409A (zh) * 2021-10-20 2022-07-01 海南倍特药业有限公司 一种注射用法莫替丁及其制备方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8703865A2 (es) * 1985-06-28 1987-03-16 Barisintex Sa Perfeccionamientos en la patente de invencion n.544661 por: procedimiento de preparazcion de ascorbatos antagonistas h2-receptores.
JP4388743B2 (ja) * 2000-11-24 2009-12-24 第一三共ヘルスケア株式会社 水溶性内服液剤
JP4828040B2 (ja) * 2001-04-27 2011-11-30 テルモ株式会社 ファモチジン注射液
WO2003055483A1 (fr) * 2001-12-27 2003-07-10 Terumo Kabushiki Kaisha Solution d'injection de famotidine
EP1504755A1 (en) * 2002-05-13 2005-02-09 Daiichi Pharmaceutical Co., Ltd. Lyophilization product

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051411A1 (fr) * 2000-12-22 2002-07-04 Yamanouchi Pharmaceutical Co., Ltd. Injections de famotidine
US7094414B2 (en) 2000-12-22 2006-08-22 Astellas Pharma Inc. Famotidine injections
CN111904936A (zh) * 2020-08-28 2020-11-10 开封康诺药业有限公司 一种法莫替丁冻干粉针剂
CN114681409A (zh) * 2021-10-20 2022-07-01 海南倍特药业有限公司 一种注射用法莫替丁及其制备方法
CN114028342A (zh) * 2021-12-08 2022-02-11 广东彼迪药业有限公司 一种法莫替丁速崩颗粒、法莫替丁片及制备方法
CN114028342B (zh) * 2021-12-08 2023-04-28 广东彼迪药业有限公司 一种法莫替丁速崩颗粒、法莫替丁片及制备方法

Also Published As

Publication number Publication date
PT75985A (en) 1983-01-01
PT75985B (en) 1985-12-05
GR77823B (ko) 1984-09-25
ES518199A0 (es) 1984-06-16
JPS6365047B2 (ko) 1988-12-14
MX7581E (es) 1989-11-24
ES8405613A1 (es) 1984-06-16
KR840002654A (ko) 1984-07-16
JPS58103312A (ja) 1983-06-20
KR880001632B1 (en) 1988-09-03

Similar Documents

Publication Publication Date Title
FI86254C (fi) Foerfarande foer framstaellning av insulinpreparat.
US4216143A (en) Soluble non-ferrous metal proteinates
Markussen et al. Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30
US4409233A (en) Highly concentrated preparations of dopa compounds
US3917824A (en) Pharmaceutical compositions containing epidermal growth factor or closely related derivatives thereof for inhibiting the secretion of acidic gastric juice in warm blooded animals
US3868358A (en) Protamine-insulin product
US3969540A (en) Enzymatically prepared metal proteinates
CA1184495A (en) Process of producing pharmaceutical composition of famotidine for injection
CA1268119A (en) Parenteral phenytoin preparations
IE841890L (en) Treatment of diabetes mellitus
IE47049B1 (en) Tetracycline antibiotic compositions
EP0868183A1 (en) Injectable quinolone formulations
JPH05503940A (ja) 新規インスリン組成物
JP2617508B2 (ja) 安定なジフェンヒドラミン含有水溶液
JPH0840907A (ja) セファロスポリン注射剤
JP2001515874A (ja) モノヒドロキサム酸塩のバナジウム錯体及び当該錯体で構成される医薬品組成物
EP0228625B1 (de) Peptid-Derivate mit inhibitorischer Wirkung auf hydroxylierende Enzyme, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung
US2407412A (en) Therapeutic solutions
JPS5865214A (ja) Ｎ−アシル−ｌ−アスパルチルタウリンを含有する医薬
NO178325B (no) Fremgangsmåte for fremstilling av et t-PA injeksjonspreparat
JP2635009B2 (ja) 安定なエルカトニン製剤
CA2152262A1 (en) Process to Prepare Pharmaceutical Compositions Containing Vecuronium Bromide
JPH0892125A (ja) 水性医薬組成物
CA1063514A (en) Water-soluble composition comprising sulfadimidine and pyrimethamine
US5399554A (en) Readily soluble 2',3'-dideoxyinosine compositions

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry